This inventor holds 1 USPTO granted patent. Top assignees: Lehigh University, Rutgers, The State University of New Jersey. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2020
Title: Karine Fabio: Innovator in Therapeutics
Introduction
Karine Fabio is a notable inventor based in La Gaude, France. She has made significant contributions to the field of therapeutics, particularly in the development of innovative drug delivery systems. Her work focuses on creating solutions that address clinical conditions requiring inflammation suppression and cholinergic intervention.
Latest Patents
Karine Fabio holds a patent for a unique dual-action therapeutic platform. This invention provides a controlled-release delivery system for non-steroidal anti-inflammatory agents on an ester or ester-carbonate backbone. The agents are reversible inhibitors of acetylcholinesterase, making them useful for various clinical conditions. The compounds are characterized by a general formula where n=0, 1; X can be C, Si, or N+, and NSAIDs include ibuprofen, naproxen, indomethacin, and diclofenac. Other embodiments of this invention are also disclosed.
Career Highlights
Throughout her career, Karine Fabio has worked with prestigious institutions such as Rutgers, the State University of New Jersey, and Lehigh University. Her experience in these organizations has allowed her to advance her research and contribute to the scientific community.
Collaborations
Karine has collaborated with esteemed colleagues, including Jeffrey D. Laskin and Diane E. Heck. These partnerships have enriched her work and fostered innovation in her field.
Conclusion
Karine Fabio's contributions to therapeutics through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to impact the field positively, showcasing the importance of research and collaboration in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile